Curtis Gale Oltmans
Chief Legal Officer · Fulcrum Therapeutics, Inc.
- 2025
- Feb 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Curtis Gale Oltmans files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $1.49M in FULC purchases and sales in the last 12 months
- Robert J. Gould - $507K in FULC purchases and sales in the last 12 months
- Alan Ezekowitz - $66K in FULC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Curtis Gale Oltmans?
Curtis Gale Oltmans is a corporate insider, tracked as Chief Legal Officer of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Curtis Gale Oltmans last file a Form 4?
The most recent primary Form 4 on record is dated 4 February 2026, one of 2 filings going back to 2025.
Has Curtis Gale Oltmans been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($45K) across all tracked filings.
